Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 1997

View Archived Issues

Watson: Q1 1997 highlights

ImmuLogic: Q1 1997 highlights

Vical: Q1 1997 highlights

Ilex Oncology: Q1 1997 highlights

Notes from Ribi's 16th Annual Meeting of Stockholders

Krenitsky seeks partners to develop MAO-A inhibitors

Krenitsky seeks partners for NGF modulators

MPL vaccine adjuvant offered for licensing by Ribi

Ribi theraccine available for licensing outside Canada

Ribi ImmunoChem offers licenses for cardioprotectant

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026